JP Morgan Upgrades Adient to Overweight, Lowers Price Target to $25

Benzinga Newsdesk www.benzinga.com Negative 45.4%

Neg 45.4% Neu 0% Pos 0%

JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.